Seizures in Hereditary Aceruloplasminemia

Massimo Marano¹, Francesco Bove², Lorenzo Ricci¹, Mohammad Rohani³, Vincenzo Di Lazzaro¹, Giovanni Assenza¹, Alfonso Fasano^{3

4

5

6

7}

Affiliations

¹ Unit of Neurology, Neurophysiology and Neurobiology, Department of Medicine, Campus Bio-Medico of Rome University, Rome, Italy.
² U.O.C. Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
³ Department of Neurology, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran.
⁴ Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, UHN, Toronto, Ontario, Canada.
⁵ Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario,Canada.
⁶ Krembil Brain Institute, Toronto, Ontario, Canada.
⁷ Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, Ontario, Canada.

Massimo Marano et al. Can J Neurol Sci. 2021 Jan.

. 2021 Jan;48(1):144-147.

doi: 10.1017/cjn.2020.171. Epub 2020 Aug 3.

Massimo Marano¹, Francesco Bove², Lorenzo Ricci¹, Mohammad Rohani³, Vincenzo Di Lazzaro¹, Giovanni Assenza¹, Alfonso Fasano^{3

4

5

6

7}

¹ Unit of Neurology, Neurophysiology and Neurobiology, Department of Medicine, Campus Bio-Medico of Rome University, Rome, Italy.
² U.O.C. Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
³ Department of Neurology, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran.
⁴ Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, UHN, Toronto, Ontario, Canada.
⁵ Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario,Canada.
⁶ Krembil Brain Institute, Toronto, Ontario, Canada.
⁷ Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, Ontario, Canada.

No abstract available

Keywords: Ceruloplasmin; Epilepsy; Ferritin; Iron; Neurodegeneration with brain iron accumulation (NBIA); Neuroferritinopathy.

Publication types